HIMSS TV

From an enterprise level there is no shortage of AI opportunities around the economic value of the application, says Dr. Peter Bonis, chief medical officer at Wolters Kluwer Health.

Telemedicine offsets waiting times and offers the ability for a clinician to step in after hours, says Carrie Nelson, chief medical officer at KeyCare.

There's a hesitancy to trust generative AI, but, at the same time, clinicians don't want to miss a diagnosis, says Dr. Antoine Keller, cardiothoracic surgeon at Ochsner Lafayette Hospital.  

Because there are barriers to adoption and trust, solutions need to be useful, be transparent around information that goes into performance and be safe, fair and cybersecure, says Dr. Sonya Makhni, medical director of applied informatics at Mayo Clinic Platform.

Deploying AI needs a strategy for use cases that starts with identifying problems that need to be solved, says Michael Pencina, director of Duke AI Health.

Accessing the funds requires a dedication of time to register and a continuing commitment for an investment longer term, says Kelly Arduino, a healthcare industry leader at Wipfli.

Telemedicine opened doors to healthcare access, says Dr. Shawn Griffin, president and CEO of URAC, a telehealth accreditor that recognizes organizations for excellence in telemedicine to boost health equity.  

Considerations include what stage of adoption hospitals are in, the challenges and benefits of the technology and the protection of patient data, says HIMSS senior market insights manager Nicole Ramage.

Generative AI is working, and the hallucination problems are easing, says Rob Havasy, senior director of informatics strategy at HIMSS.

Providence is starting to see scale on AI in clinical use cases and in implementation evaluation, says Dr. Eve Cunningham, chief of virtual care and digital health at Providence.